FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Mintun

Research Profile

Procedures

Disorders

Anatomy

Brain

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Image Processing, Computer-Assisted

Co-author Network

Publications

TOP 3
Reisa A Sperling; Alan Carpenter; Christopher M Clark; Mat D Davis; P Murali Doraiswamy; Adam S Fleisher; Matthew Flitter; Michael Grundman; Keith A Johnson; Abhinay D Joshi; Ming Lu; Mark A Mintun; Michael J Pontecorvo; Eric Reiman; Marwan N Sabbagh; Carl H Sadowsky; Daniel M Skovronsky
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.
Michael Grundman; Michael J Krautkramer; Ming Lu; Mark A Mintun; Anil K Nair; Michael J Pontecorvo; Carl H Sadowsky; Stephen P Salloway; Khaled Sarsour; Andrew Siderowf; Daniel M Skovronsky; Abigail Agbulos; Anupa K Arora; P Murali Doraiswamy; Adam S Fleisher; Matthew L Flitter
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.
Susan M Landau; Chester A Mathis; Mark A Mintun; Michael Pontecorvo; Christopher Breault; William J Jagust; Abhinay D Joshi
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Mintun (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Reisa A Sperling; Alan Carpenter; Christopher M Clark; Mat D Davis; P Murali Doraiswamy; Adam S Fleisher; Matthew Flitter; Michael Grundman; Keith A Johnson; Abhinay D Joshi; Ming Lu; Mark A Mintun; Michael J Pontecorvo; Eric Reiman; Marwan N Sabbagh; Carl H Sadowsky; Daniel M Skovronsky
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.
Neurobiology of aging 2013;34(3):822-31.
2013: Michael Grundman; Michael J Krautkramer; Ming Lu; Mark A Mintun; Anil K Nair; Michael J Pontecorvo; Carl H Sadowsky; Stephen P Salloway; Khaled Sarsour; Andrew Siderowf; Daniel M Skovronsky; Abigail Agbulos; Anupa K Arora; P Murali Doraiswamy; Adam S Fleisher; Matthew L Flitter
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.
Alzheimer disease and associated disorders 2013;27(1):4-15.
2013: Susan M Landau; Chester A Mathis; Mark A Mintun; Michael Pontecorvo; Christopher Breault; William J Jagust; Abhinay D Joshi
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(1):70-7.
2013: Yi Su; Andrei G Vlassenko; Abraham Z Snyder; Ana M Arbelaez; Tammie L S Benzinger; Mark A Mintun; Marcus E Raichle
Noninvasive estimation of the arterial input function in positron emission tomography imaging of cerebral blood flow.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2013;33(1):115-21.
2013: Adam S Fleisher; Keith A Johnson; Abhinay D Joshi; Xiaofen Liu; Mark A Mintun; Michael J Pontecorvo; Hillary Protas; Napatkamon Ayutyanont; Alan P Carpenter; Kewei Chen; Christopher M Clark; R Edward Coleman; P M Doraiswamy; Auttawut Roontiva; Marwan Sabbagh; Carl H Sadowsky; Daniel M Skovronsky; Reisa A Sperling; Pradeep Thiyyagura; Eric Reiman
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
Neurobiology of aging 2013;34(1):1-12.
2012: P Murali Doraiswamy; Adam S Fleisher; Michael Grundman; Keith A Johnson; Abhinay D Joshi; Mark A Mintun; Michael J Pontecorvo; Eric Reiman; Marwan N Sabbagh; Carl H Sadowsky; Daniel M Skovronsky; Reisa A Sperling; Alan Carpenter; Christopher M Clark; R Edward Coleman; Mat D Davis
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
Neurology 2012;79(16):1636-44.
2012: Susan M Landau; Mark A Mintun; Ronald C Petersen; Michael W Weiner; Paul S Aisen; William J Jagust; Abhinay D Joshi; Robert A Koeppe
Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Annals of neurology 2012;72(4):578-86.
2012: Christopher M Clark; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Matthew L Flitter; Abhinay D Joshi; Michael J Krautkramer; Ming Lu; Mark A Mintun; Michael J Pontecorvo; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Daniel M Skovronsky; Anupa Arora; Thomas G Beach; Barry J Bedell; Alan P Carpenter
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Lancet neurology 2012;11(8):669-78.
2012: Charles R Conway; Sunil Gangwani; Luis A Giuffra; Tamara Hershey; Mark A Mintun; Joseph L Price; Richard D Bucholz; John T Chibnall; Jon J Christensen; Yvette I Sheline
Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?
Journal of affective disorders 2012;139(3):283-90.
2012: Denise Head; David M Holtzman; Mark A Mintun; Tammie Benzinger; Julie M Bugg; Anne M Fagan; Alison M Goate; John C Morris
Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
Archives of neurology 2012;69(5):636-43.
2012: Charles R Conway; Sunil Gangwani; Richard D Bucholz; John T Chibnall; Joseph L Price; Yvette I Sheline; Mark A Mintun
Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.
Brain stimulation 2012;5(2):163-71.
2012: Abhinay D Joshi; Karel D Kovnat; Mark J Lowrey; Mark A Mintun; Michael J Pontecorvo; Carl H Sadowsky; Krishnendu Saha; John P Seibyl; Daniel M Skovronsky; Lee P Adler; Anupa Arora; Jason D Burns; Alan P Carpenter; Chrisopher M Clark; Danna L Jennings
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(3):378-84.
2011: Adam S Fleisher; Keith A Johnson; Abhinay D Joshi; Xiaofen Liu; Mark A Mintun; Michael J Pontecorvo; Napatkamon Ayutyanont; Kewei Chen; Christopher M Clark; P Murali Doraiswamy; Auttawut Roontiva; Daniel M Skovronsky; Pradeep Thiyyagura; Eric M Reiman
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Archives of neurology 2011;68(11):1404-11.
2011: John R Cirrito; Gina D'Angelo; Brianne M Disabato; Whitney D Goebel; Davinder Hayreh; Jungsu Kim; Mark A Mintun; John C Morris; Jessica L Restivo; Anshul Sathyan; Deborah K Verges; Hyejin Yoon; Tammie Benzinger; Yvette I Sheline
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(36):14968-73.
2011: Catherine M Roe; Tammie L S Benzinger; Anne M Fagan; Elizabeth A Grant; David M Holtzman; Daniel S Marcus; Mark A Mintun; John C Morris
Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.
Archives of neurology 2011;68(9):1145-51.
2011: Anne M Fagan; Els Coart; Mark A Mintun; John C Morris; Leslie M Shaw; John Q Trojanowski; hugo vanderstichele; Chengjie Xiong; David M Holtzman
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.
Archives of neurology 2011;68(9):1137-44.
2011: Rawan Tarawneh; Chengjie Xiong; Nigel J Cairns; Deborah Carter; Gina D'Angelo; Anne M Fagan; Denise Head; Jack H Ladenson; Jin-Moo Lee; Elizabeth Macy; Mark A Mintun; John C Morris; David M Holtzman
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease.
Annals of neurology 2011;70(2):274-85.
2011: Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.
Synapse (New York, N.Y.) 2011;65(8):724-32.
2011: John Lister-James; Michael J Pontecorvo; Chris Clark; Abhinay D Joshi; Mark A Mintun; Wei Zhang; Nathaniel Lim; Zhiping Zhuang; Geoff Golding; Seok-Rye Choi; Tyler E Benedum; Paul Kennedy; Franz Hefti; Alan P Carpenter; Hank F Kung; Daniel M Skovronsky
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
Seminars in nuclear medicine 2011;41(4):300-4.
2011: Catherine M Roe; Anne M Fagan; M M Williams; Nupur Ghoshal; M Aeschleman; Elizabeth A Grant; Daniel S Marcus; Mark A Mintun; David M Holtzman; John C Morris
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease.
Neurology 2011;76(6):501-10.
2011: Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Use of florbetapir-PET for imaging beta-amyloid pathology.
JAMA : the journal of the American Medical Association 2011;305(3):275-83.
2011: Michael J Pontecorvo; Mark A Mintun
PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease.
Alzheimer's research & therapy 2011;3(2):11.
2010: Yvette I Sheline; John C Morris; Abraham Z Snyder; Joseph L Price; Zhizi Yan; Gina D'Angelo; Collin Liu; Sachin Dixit; Tammie Benzinger; Anne M Fagan; Alison Goate; Mark A Mintun
APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(50):17035-40.
2010: Rebecca Craig-Schapiro; Richard J Perrin; Catherine M Roe; Chengjie Xiong; Deborah Carter; Nigel J Cairns; Mark A Mintun; Elaine Peskind; Ge Li; Douglas Galasko; Christopher M Clark; Joseph F Quinn; Gina D'Angelo; James P Malone; R Reid Townsend; John C Morris; Anne M Fagan; David M Holtzman
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.
Biological psychiatry 2010;68(10):903-12.
2010: James E Galvin; Anne M Fagan; David M Holtzman; Mark A Mintun; John C Morris
Relationship of dementia screening tests with biomarkers of Alzheimer's disease.
Brain : a journal of neurology 2010;133(11):3290-300.
2010: S Neil Vaishnavi; Andrei G Vlassenko; Melissa M Rundle; Abraham Z Snyder; Mark A Mintun; Marcus E Raichle
Regional aerobic glycolysis in the human brain.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(41):17757-62.
2010: Andrei G Vlassenko; S Neil Vaishnavi; Lars Couture; Dana Sacco; Benjamin J Shannon; Robert H Mach; John C Morris; Marcus E Raichle; Mark A Mintun
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(41):17763-7.
2010: Kelvin Y Liang; Mark A Mintun; Anne M Fagan; Alison Goate; Julie M Bugg; David M Holtzman; John C Morris; Denise Head
Exercise and Alzheimer's disease biomarkers in cognitively normal older adults.
Annals of neurology 2010;68(3):311-8.
2010: Beau M Ances; J J Christensen; M Teshome; J Taylor; Chengjie Xiong; P Aldea; Anne M Fagan; David M Holtzman; John C Morris; Mark A Mintun; David B Clifford
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study.
Neurology 2010;75(2):111-5.
2010: Catherine M Roe; Mark A Mintun; Nupur Ghoshal; M M Williams; Elizabeth A Grant; Daniel S Marcus; John C Morris
Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.
Neurology 2010;75(1):42-8.
2010: Yvette I Sheline; Joseph L Price; Zhizi Yan; Mark A Mintun
Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(24):11020-5.
2010: Jinbin Xu; Babak Hassanzadeh; Wenhua Chu; Zhude Tu; Lynne A Jones; Robert R Luedtke; Joel S Perlmutter; Mark A Mintun; Robert H Mach
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.
Synapse (New York, N.Y.) 2010;64(6):449-59.
2010: Anthony L Hinrichs; Mark A Mintun; Denise Head; Anne M Fagan; David M Holtzman; John C Morris; Alison Goate
Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.
Biological psychiatry 2010;67(6):581-3.
2010: Yvette I Sheline; Marcus E Raichle; Abraham Z Snyder; John C Morris; Denise Head; Suzhi Wang; Mark A Mintun
Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly.
Biological psychiatry 2010;67(6):584-7.
2010: Chenbo Zeng; Fenghui Pan; Lynne A Jones; Miranda M Lim; Elizabeth A Griffin; Yvette I Sheline; Mark A Mintun; David M Holtzman; Robert H Mach
Evaluation of 5-ethynyl-2'-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system.
Brain research 2010;1319():21-32.
2010: John C Morris; Catherine M Roe; Chengjie Xiong; Anne M Fagan; Alison Goate; David M Holtzman; Mark A Mintun
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.
Annals of neurology 2010;67(1):122-31.
2009: Nigel J Cairns; Milos D Ikonomovic; Tammie Benzinger; Martha Storandt; Anne M Fagan; Aarti R Shah; Lisa Taylor Reinwald; Deborah Carter; Angela Felton; David M Holtzman; Mark A Mintun; William E Klunk; John C Morris
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.
Archives of neurology 2009;66(12):1557-62.
2009: Martha Storandt; Mark A Mintun; Denise Head; John C Morris
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition.
Archives of neurology 2009;66(12):1476-81.
2009: John C Morris; Catherine M Roe; Elizabeth A Grant; Denise Head; Martha Storandt; Alison Goate; Anne M Fagan; David M Holtzman; Mark A Mintun
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
Archives of neurology 2009;66(12):1469-75.
2009: Tammie L S Benzinger; David Brody; Sylvain Cardin; Kenneth Clark Curley; Mark A Mintun; Seong Mun; Kenneth H Wong; Jean R Wrathall
Blast-related brain injury: imaging for clinical and research applications: report of the 2008 st. Louis workshop.
Journal of neurotrauma 2009;26(12):2127-44.
2009: Anne M Fagan; Mark A Mintun; Aarti R Shah; Patricia Aldea; Catherine M Roe; Robert H Mach; Daniel Marcus; John C Morris; David M Holtzman
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease.
EMBO molecular medicine 2009;1(8-9):371-80.
2009: Delphine L Chen; Timothy J Bedient; James Kozlowski; Daniel B Rosenbluth; Warren Isakow; Thomas W Ferkol; Betsy Thomas; Mark A Mintun; Daniel P Schuster; Michael J Walter
[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.
American journal of respiratory and critical care medicine 2009;180(6):533-9.
2009: Jinbin Xu; Wenhua Chu; Zhude Tu; Lynne A Jones; Robert R Luedtke; Joel S Perlmutter; Mark A Mintun; Robert H Mach
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.
Synapse (New York, N.Y.) 2009;63(9):717-28.
2009: Joshua S Shimony; Yvette I Sheline; Gina D'Angelo; Adrian A Epstein; Tammie L S Benzinger; Mark A Mintun; Robert C McKinstry; Abraham Z Snyder
Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study.
Biological psychiatry 2009;66(3):245-52.
2009: Yvette I Sheline; Deanna M Barch; Joseph L Price; Melissa M Rundle; S Neil Vaishnavi; Abraham Z Snyder; Mark A Mintun; Suzhi Wang; Rebecca S Coalson; Marcus E Raichle
The default mode network and self-referential processes in depression.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(6):1942-7.
2009: Christina L Fales; Deanna M Barch; Melissa M Rundle; Mark A Mintun; Jose Mathews; Abraham Z Snyder; Yvette I Sheline
Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression.
Journal of affective disorders 2009;112(1-3):206-11.
2008: Catherine M Roe; Mark A Mintun; Gina D'Angelo; Chengjie Xiong; Elizabeth A Grant; John C Morris
Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.
Archives of neurology 2008;65(11):1467-71.
2008: Mark A Mintun
FDG and amyloid positron emission tomography.
CNS spectrums 2008;13(10 Suppl 16):21-4.
2008: Yvette I Sheline; Joseph L Price; S Neil Vaishnavi; Mark A Mintun; Deanna M Barch; Adrian A Epstein; Consuelo H Wilkins; Abraham Z Snyder; Lars Couture; Kenneth Schechtman; Robert C McKinstry
Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors.
The American journal of psychiatry 2008;165(4):524-32.
2008: Christina L Fales; Deanna M Barch; Melissa M Rundle; Mark A Mintun; Abraham Z Snyder; Jonathan D Cohen; Jose Mathews; Yvette I Sheline
Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression.
Biological psychiatry 2008;63(4):377-84.
2008: Anthony F Fotenos; Mark A Mintun; Abraham Z Snyder; John C Morris; Randy L Buckner
Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.
Archives of neurology 2008;65(1):113-20.
2007: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte Moos Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin V Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(9):1533-9.
2007: Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Archives of neurology 2007;64(3):343-9.
2006: Andrei G Vlassenko; Melissa M Rundle; Mark A Mintun
Human brain glucose metabolism may evolve during activation: findings from a modified FDG PET paradigm.
NeuroImage 2006;33(4):1036-41.
2006: Mark A Mintun; Gina N LaRossa; Yvette I Sheline; Carmen S Dence; S Y Lee; Robert H Mach; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.
Neurology 2006;67(3):446-52.
2006: Delphine L Chen; Thomas Ferkol; Mark A Mintun; Jessica E Pittman; Daniel B Rosenbluth; Daniel P Schuster
Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.
American journal of respiratory and critical care medicine 2006;173(12):1363-9.
2006: Delphine L Chen; Daniel B Rosenbluth; Mark A Mintun; Daniel P Schuster
FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin.
Journal of applied physiology (Bethesda, Md. : 1985) 2006;100(5):1602-9.
2006: Jose Mathews; Keith S Garcia; Mark A Mintun; Yvette I Sheline
Antidepressant efficacy of olanzapine as monotherapy in major depressive disorder, without psychosis: a pilot study.
Psychiatry research 2006;146(2):149-55.
2006: Charles R Conway; Yvette I Sheline; John T Chibnall; Mark Stork George; James W Fletcher; Mark A Mintun
Cerebral blood flow changes during vagus nerve stimulation for depression.
Psychiatry research 2006;146(2):179-84.
2006: Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
Annals of neurology 2006;59(3):512-9.
2006: Andrei G Vlassenko; Melissa M Rundle; Marcus E Raichle; Mark A Mintun
Regulation of blood flow in activated human brain by cytosolic NADH/NAD+ ratio.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(6):1964-9.
2006: Marcus E Raichle; Mark A Mintun
Brain work and brain imaging.
Annual review of neuroscience 2006;29():449-76.
2005: Mark A Mintun
Utilizing advanced imaging and surrogate markers across the spectrum of Alzheimer's disease.
CNS spectrums 2005;10(11 Suppl 18):13-6.
2005: Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina N LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(34):7709-17.
2004: Yvette I Sheline; Mark A Mintun; Deanna M Barch; Consuelo H Wilkins; Abraham Z Snyder; Stephen M Moerlein
Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(12):2235-41.
2004: Delphine L Chen; Mark A Mintun; Daniel P Schuster
Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(9):1583-90.
2004: Jeffrey D. Bradley; Farrokh Dehdashti; Mark A Mintun; Ramaswamy Govindan; Kim Trinkaus; Barry A Siegel
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3248-54.
2004: Jean-Christophe Richard; Zhaohui Zhou; Delphine L Chen; Mark A Mintun; David Piwnica-Worms; Phillip H. Factor; Datta E Ponde; Daniel P Schuster
Quantitation of pulmonary transgene expression with PET imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):644-54.
2004: Mark A Mintun; Yvette I Sheline; Stephen M Moerlein; Andrei G Vlassenko; Yiyun Huang; Abraham Z Snyder
Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
Biological psychiatry 2004;55(3):217-24.
2004: Mark A Mintun; Andrei G Vlassenko; Melissa M Rundle; Marcus E Raichle
Increased lactate/pyruvate ratio augments blood flow in physiologically activated human brain.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(2):659-64.
2004: Andrei G Vlassenko; Yvette I Sheline; Keith Fischer; Mark A Mintun
Cerebral perfusion response to successful treatment of depression with different serotoninergic agents.
The Journal of neuropsychiatry and clinical neurosciences 2004;16(3):360-3.
2003: Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.
European journal of nuclear medicine and molecular imaging 2003;30(6):844-50.
2003: Farrokh Dehdashti; Perry W Grigsby; Mark A Mintun; Jason S Lewis; Barry A Siegel; Michael J Welch
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
International journal of radiation oncology, biology, physics 2003;55(5):1233-8.
2002: Kevin J. Black; Tamara Hershey; Jonathan M Koller; Tom O Videen; Mark A Mintun; Joseph L Price; Joel S Perlmutter
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(26):17113-8.
2002: Yvette I Sheline; B L Mittler; Mark A Mintun
The hippocampus and depression.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17 Suppl 3():300-5.
2002: Mark A Mintun; Andrei G Vlassenko; Gordon L Shulman; Abraham Z Snyder
Time-related increase of oxygen utilization in continuously activated human visual cortex.
NeuroImage 2002;16(2):531-7.
2002: Yvette I Sheline; Mark A Mintun; Stephen M Moerlein; Abraham Z Snyder
Greater loss of 5-HT(2A) receptors in midlife than in late life.
The American journal of psychiatry 2002;159(3):430-5.
2001: Yvette I Sheline; Deanna M Barch; J M Donnelly; John M Ollinger; Abraham Z Snyder; Mark A Mintun
Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.
Biological psychiatry 2001;50(9):651-8.
2001: Mark A Mintun; B N Lundstrom; Abraham Z Snyder; Andrei G Vlassenko; Gordon L Shulman; Marcus E Raichle
Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6859-64.
2001: K.S. Chao; Walter Bosch; Sasa Mutic; Jason S Lewis; Farrokh Dehdashti; Mark A Mintun; James F Dempsey; Carlos A Perez; James A Purdy; M J Welch
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
International journal of radiation oncology, biology, physics 2001;49(4):1171-82.
1999: Yvette I Sheline; M Sanghavi; Mark A Mintun; Mokhtar H Gado
Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(12):5034-43.